Researchers based in Germany have developed a perfusion process for the manufacture of oncolytic viruses. The team from the Max Planck Institute says that the new approach aims to improve virus titers ...

In a recent review, Trent Munro, PhD, National Biologics Facility, University of Queensland, Australia, writes that “Improvements in process and cell line development, the advent of single-use ...

The demand for producing therapeutic recombinant proteins is generating a renewed interest in perfusion cell culture technologies, leading to the development of cell culture media that can support ...

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced that National Resilience, Inc.

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry today announced the launch of the ambr ® 250 high throughput (ht) perfusion, a new automated ...

Achieving high cell densities in long-term cultures is often a challenge facing bioprocessing manufacturers, and one that requires the support of optimal media. FUJIFILM Irvine Scientific recently sat ...

The perfusion study demonstrates the ability to achieve high infectious titers using continuous bioprocess technologies that are associated with many other production benefits. The debottlenecking ...

It goes without saying that the greater the number of organs available for transplant, the better for patients in need of them. A newly-developed technique could help, as it uses light to kill viruses ...